Mostrar el registro sencillo del ítem

dc.contributor.authorEstevez Loureiro, Rodrigo 
dc.contributor.authorTavares Da Silva, M.
dc.contributor.authorBaz Alonso, José Antonio 
dc.contributor.authorCaneiro Queija, Berenice
dc.contributor.authorBarreiro Perez, Manuel
dc.contributor.authorCalvo Iglesias, Francisco 
dc.contributor.authorGonzález Ferreiro, Rocío 
dc.contributor.authorPuga, L.
dc.contributor.authorPiñón, M.
dc.contributor.authorIñiguez Romo, Andres 
dc.date.accessioned2025-08-26T11:20:45Z
dc.date.available2025-08-26T11:20:45Z
dc.date.issued2022
dc.identifier.citationEstévez-Loureiro R, Tavares Da Silva M, Baz-Alonso JA, Caneiro-Queija B, Barreiro-Pérez M, Calvo-Iglesias F, et al. Percutaneous mitral valve repair in patients developing severe mitral regurgitation early after an acute myocardial infarction: A review. Frontiers in Cardiovascular Medicine.
dc.identifier.issn2297-055X
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/635da1dcf50cf01a7960f66d*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20897
dc.description.abstractAcute mitral regurgitation (MR) may develop in the setting of an acute myocardial infarction (AMI) because of papillary muscle dysfunction or rupture. Severe acute MR in this scenario is a life-threatening complication associated with hemodynamic instability and pulmonary edema, and has been linked to a worse prognosis even after reperfusion. Patients treated solely with medical therapy have the highest mortality rates. Surgery has been the only treatment strategy until recently, but the results of the technique are hindered by high rates of morbidity and mortality. Therefore, the development of less invasive interventions for correcting MR would be ideal. We aimed to review the current role of transcatheter interventions in this clinical setting.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titlePercutaneous mitral valve repair in patients developing severe mitral regurgitation early after an acute myocardial infarction: A review*
dc.typeReviewen
dc.authorsophosEstévez-Loureiro, A. R.
dc.authorsophosTavares Da Silva, M.
dc.authorsophosBaz-Alonso, J. A.
dc.authorsophosCaneiro-Queija, B.
dc.authorsophosBarreiro-Pérez, M.
dc.authorsophosCalvo-Iglesias, F.
dc.authorsophosGonzález-Ferreiro, R.
dc.authorsophosPuga, L.
dc.authorsophosPiñón, M.
dc.authorsophosÍñiguez, Romo
dc.identifier.doi10.3389/fcvm.2022.987122
dc.identifier.sophos635da1dcf50cf01a7960f66d
dc.journal.titleFrontiers in Cardiovascular Medicine*
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fcvm.2022.987122/pdf;https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.987122/pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Vigoes
dc.subject.keywordCHUVIes
dc.subject.keywordIISGSes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number9


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional